Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.84799894 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.84799894 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.65855203 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.65855203 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.02660720 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.01726505 |
7 | alpha-linolenic acid metabolic process (GO:0036109) | 5.53776325 |
8 | sulfur amino acid catabolic process (GO:0000098) | 5.53618793 |
9 | tryptophan catabolic process (GO:0006569) | 5.33965803 |
10 | indole-containing compound catabolic process (GO:0042436) | 5.33965803 |
11 | indolalkylamine catabolic process (GO:0046218) | 5.33965803 |
12 | glyoxylate metabolic process (GO:0046487) | 5.32873247 |
13 | bile acid biosynthetic process (GO:0006699) | 5.30353599 |
14 | kynurenine metabolic process (GO:0070189) | 5.18981127 |
15 | serine family amino acid catabolic process (GO:0009071) | 5.12664833 |
16 | urea cycle (GO:0000050) | 5.10417697 |
17 | urea metabolic process (GO:0019627) | 5.10417697 |
18 | tryptophan metabolic process (GO:0006568) | 5.05445547 |
19 | cysteine metabolic process (GO:0006534) | 5.04134253 |
20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.00071314 |
21 | high-density lipoprotein particle remodeling (GO:0034375) | 4.98331632 |
22 | regulation of triglyceride catabolic process (GO:0010896) | 4.83400545 |
23 | nitrogen cycle metabolic process (GO:0071941) | 4.76540457 |
24 | bile acid metabolic process (GO:0008206) | 4.65484195 |
25 | amino-acid betaine metabolic process (GO:0006577) | 4.65035455 |
26 | negative regulation of fibrinolysis (GO:0051918) | 4.63637174 |
27 | regulation of cholesterol esterification (GO:0010872) | 4.58441694 |
28 | aromatic amino acid family metabolic process (GO:0009072) | 4.55810462 |
29 | protein carboxylation (GO:0018214) | 4.53934670 |
30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.53934670 |
31 | complement activation, alternative pathway (GO:0006957) | 4.47827776 |
32 | plasma lipoprotein particle remodeling (GO:0034369) | 4.44454523 |
33 | protein-lipid complex remodeling (GO:0034368) | 4.44454523 |
34 | macromolecular complex remodeling (GO:0034367) | 4.44454523 |
35 | glycine metabolic process (GO:0006544) | 4.42570782 |
36 | cellular ketone body metabolic process (GO:0046950) | 4.41611752 |
37 | regulation of protein activation cascade (GO:2000257) | 4.41596398 |
38 | triglyceride homeostasis (GO:0070328) | 4.41117628 |
39 | acylglycerol homeostasis (GO:0055090) | 4.41117628 |
40 | regulation of fibrinolysis (GO:0051917) | 4.41110913 |
41 | alpha-amino acid catabolic process (GO:1901606) | 4.34262391 |
42 | reverse cholesterol transport (GO:0043691) | 4.33230715 |
43 | lysine catabolic process (GO:0006554) | 4.32448839 |
44 | lysine metabolic process (GO:0006553) | 4.32448839 |
45 | tyrosine metabolic process (GO:0006570) | 4.26095774 |
46 | phospholipid efflux (GO:0033700) | 4.24597174 |
47 | plasma lipoprotein particle clearance (GO:0034381) | 4.23432608 |
48 | homocysteine metabolic process (GO:0050667) | 4.16587647 |
49 | serine family amino acid metabolic process (GO:0009069) | 4.15682602 |
50 | negative regulation of cholesterol transport (GO:0032375) | 4.14801436 |
51 | negative regulation of sterol transport (GO:0032372) | 4.14801436 |
52 | regulation of complement activation (GO:0030449) | 4.11676876 |
53 | coenzyme catabolic process (GO:0009109) | 4.10187150 |
54 | cellular amino acid catabolic process (GO:0009063) | 4.09664502 |
55 | ethanol oxidation (GO:0006069) | 4.06117616 |
56 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.05123334 |
57 | negative regulation of cell killing (GO:0031342) | 4.05123334 |
58 | GDP-mannose metabolic process (GO:0019673) | 4.01733593 |
59 | bile acid and bile salt transport (GO:0015721) | 3.97219098 |
60 | serine family amino acid biosynthetic process (GO:0009070) | 3.96838570 |
61 | acetyl-CoA metabolic process (GO:0006084) | 3.91640724 |
62 | fatty acid beta-oxidation (GO:0006635) | 3.85140442 |
63 | indolalkylamine metabolic process (GO:0006586) | 3.81597688 |
64 | ketone body metabolic process (GO:1902224) | 3.80710574 |
65 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.80325296 |
66 | low-density lipoprotein particle remodeling (GO:0034374) | 3.79208063 |
67 | organic acid catabolic process (GO:0016054) | 3.78613089 |
68 | carboxylic acid catabolic process (GO:0046395) | 3.78613089 |
69 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.78403768 |
70 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.78403768 |
71 | cellular glucuronidation (GO:0052695) | 3.77516376 |
72 | imidazole-containing compound metabolic process (GO:0052803) | 3.75664183 |
73 | cholesterol efflux (GO:0033344) | 3.74719657 |
74 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.74699922 |
75 | amine catabolic process (GO:0009310) | 3.74251477 |
76 | cellular biogenic amine catabolic process (GO:0042402) | 3.74251477 |
77 | fatty acid oxidation (GO:0019395) | 3.73838852 |
78 | positive regulation of lipid catabolic process (GO:0050996) | 3.72994138 |
79 | plasma lipoprotein particle assembly (GO:0034377) | 3.72906005 |
80 | short-chain fatty acid metabolic process (GO:0046459) | 3.70641087 |
81 | fatty acid catabolic process (GO:0009062) | 3.70088825 |
82 | aldehyde catabolic process (GO:0046185) | 3.69783326 |
83 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.69343768 |
84 | benzene-containing compound metabolic process (GO:0042537) | 3.69292258 |
85 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.67601320 |
86 | lipid oxidation (GO:0034440) | 3.67025709 |
87 | arginine metabolic process (GO:0006525) | 3.64383693 |
88 | monocarboxylic acid catabolic process (GO:0072329) | 3.63365107 |
89 | cofactor catabolic process (GO:0051187) | 3.62561268 |
90 | carnitine metabolic process (GO:0009437) | 3.60852281 |
91 | valine metabolic process (GO:0006573) | 3.59183609 |
92 | drug catabolic process (GO:0042737) | 3.57983516 |
93 | metallo-sulfur cluster assembly (GO:0031163) | 3.57564313 |
94 | iron-sulfur cluster assembly (GO:0016226) | 3.57564313 |
95 | cholesterol homeostasis (GO:0042632) | 3.55029847 |
96 | glutamate metabolic process (GO:0006536) | 3.54514271 |
97 | 2-oxoglutarate metabolic process (GO:0006103) | 3.53912246 |
98 | neutrophil activation involved in immune response (GO:0002283) | 3.53052698 |
99 | cellular modified amino acid catabolic process (GO:0042219) | 3.52730659 |
100 | base-excision repair, AP site formation (GO:0006285) | 3.51472843 |
101 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.49520188 |
102 | blood coagulation, intrinsic pathway (GO:0007597) | 3.49141948 |
103 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.48177650 |
104 | negative regulation of lipase activity (GO:0060192) | 3.48067144 |
105 | sterol homeostasis (GO:0055092) | 3.46803810 |
106 | biotin metabolic process (GO:0006768) | 3.46507323 |
107 | flavonoid metabolic process (GO:0009812) | 3.45435300 |
108 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.44434080 |
109 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.43841920 |
110 | plasma lipoprotein particle organization (GO:0071827) | 3.43209501 |
111 | heme transport (GO:0015886) | 3.42657156 |
112 | branched-chain amino acid catabolic process (GO:0009083) | 3.42018409 |
113 | uronic acid metabolic process (GO:0006063) | 3.40785553 |
114 | glucuronate metabolic process (GO:0019585) | 3.40785553 |
115 | immunoglobulin mediated immune response (GO:0016064) | 3.33274998 |
116 | DNA deamination (GO:0045006) | 3.19571779 |
117 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.14129828 |
118 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.09201149 |
119 | response to interferon-beta (GO:0035456) | 2.99927770 |
120 | NIK/NF-kappaB signaling (GO:0038061) | 2.97876063 |
121 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.96420556 |
122 | negative regulation of innate immune response (GO:0045824) | 2.95702164 |
123 | autophagic vacuole fusion (GO:0000046) | 2.94283469 |
124 | positive regulation of B cell differentiation (GO:0045579) | 2.92839120 |
125 | regulation of defense response to virus by virus (GO:0050690) | 2.88795531 |
126 | positive regulation of T cell apoptotic process (GO:0070234) | 2.88671669 |
127 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.87897669 |
128 | detection of bacterium (GO:0016045) | 2.86263186 |
129 | positive regulation of defense response to virus by host (GO:0002230) | 2.84943967 |
130 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.84627922 |
131 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.84485734 |
132 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.83155989 |
133 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.83073161 |
134 | positive regulation by symbiont of host defense response (GO:0052509) | 2.82690971 |
135 | modulation by symbiont of host defense response (GO:0052031) | 2.82690971 |
136 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.82690971 |
137 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.82690971 |
138 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.82690971 |
139 | modulation by symbiont of host immune response (GO:0052553) | 2.82690971 |
140 | response to peptidoglycan (GO:0032494) | 2.81907417 |
141 | positive thymic T cell selection (GO:0045059) | 2.81647424 |
142 | cellular response to interferon-beta (GO:0035458) | 2.80486173 |
143 | cellular response to type I interferon (GO:0071357) | 2.77503762 |
144 | type I interferon signaling pathway (GO:0060337) | 2.77503762 |
145 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.76332136 |
146 | response to type I interferon (GO:0034340) | 2.74310345 |
147 | neutrophil activation (GO:0042119) | 2.72099806 |
148 | regulation of defense response to virus by host (GO:0050691) | 2.71925030 |
149 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.70651619 |
150 | respiratory burst (GO:0045730) | 2.70490361 |
151 | leukocyte aggregation (GO:0070486) | 2.69871120 |
152 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.68836771 |
153 | positive regulation of antigen processing and presentation (GO:0002579) | 2.67907329 |
154 | detection of other organism (GO:0098543) | 2.66958123 |
155 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.66148560 |
156 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.64879666 |
157 | deoxyribonucleotide catabolic process (GO:0009264) | 2.64222220 |
158 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.61294734 |
159 | granulocyte activation (GO:0036230) | 2.61198415 |
160 | regulation of gamma-delta T cell activation (GO:0046643) | 2.58891122 |
161 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.58008488 |
162 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.56493272 |
163 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.55078817 |
164 | leukocyte degranulation (GO:0043299) | 2.54387503 |
165 | negative regulation of phagocytosis (GO:0050765) | 2.54030434 |
166 | negative regulation of interleukin-12 production (GO:0032695) | 2.52160706 |
167 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.48027094 |
168 | T cell migration (GO:0072678) | 2.47883919 |
169 | myeloid cell activation involved in immune response (GO:0002275) | 2.46725052 |
170 | thymic T cell selection (GO:0045061) | 2.46029621 |
171 | viral protein processing (GO:0019082) | 2.46011112 |
172 | regulation of antigen processing and presentation (GO:0002577) | 2.45997704 |
173 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.43787345 |
174 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.43231547 |
175 | tolerance induction (GO:0002507) | 2.42349238 |
176 | negative T cell selection (GO:0043383) | 2.42269503 |
177 | deoxyribose phosphate catabolic process (GO:0046386) | 2.41585782 |
178 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.41316121 |
179 | regulation of autophagic vacuole assembly (GO:2000785) | 2.41306622 |
180 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.39127806 |
181 | positive T cell selection (GO:0043368) | 2.39080845 |
182 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.37448349 |
183 | T cell selection (GO:0045058) | 2.37063659 |
184 | negative thymic T cell selection (GO:0045060) | 2.36784735 |
185 | negative regulation of interleukin-6 production (GO:0032715) | 2.36569319 |
186 | mannosylation (GO:0097502) | 2.36206068 |
187 | modulation by virus of host process (GO:0019054) | 2.35721474 |
188 | macrophage activation involved in immune response (GO:0002281) | 2.35257910 |
189 | regulation of B cell differentiation (GO:0045577) | 2.35087168 |
190 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.34858115 |
191 | B cell mediated immunity (GO:0019724) | 2.32260264 |
192 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.32125506 |
193 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.32125506 |
194 | positive regulation of protein homooligomerization (GO:0032464) | 2.31847967 |
195 | negative regulation of type I interferon production (GO:0032480) | 2.31556808 |
196 | B cell receptor signaling pathway (GO:0050853) | 2.30673537 |
197 | regulation of cell killing (GO:0031341) | 2.29202400 |
198 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.28494863 |
199 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.27930677 |
200 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.27756431 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.34591161 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.41779708 |
3 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.41468979 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.97692941 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.53529677 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.00406137 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.83114008 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.82655592 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.13564481 |
10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.07070719 |
11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.97989176 |
12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.66933202 |
13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.09065772 |
14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.01040871 |
15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4566075 |
16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.86677559 |
17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.85875909 |
18 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.85865379 |
19 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.85176650 |
20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.84719454 |
21 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83870294 |
22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.81165229 |
23 | UTX_26944678_Chip-Seq_JUKART_Human | 1.80454268 |
24 | MYC_22102868_ChIP-Seq_BL_Human | 1.80283118 |
25 | MAF_26560356_Chip-Seq_TH1_Human | 1.80026075 |
26 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.76970337 |
27 | MAF_26560356_Chip-Seq_TH2_Human | 1.73668396 |
28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.70554822 |
29 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.67758386 |
30 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.66139856 |
31 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.60496844 |
32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.59974254 |
33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.55724111 |
34 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53570234 |
35 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53564816 |
36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.52319891 |
37 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.47553435 |
38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.47330176 |
39 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.45303523 |
40 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.45258861 |
41 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.44916657 |
42 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.44914750 |
43 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.43992595 |
44 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.43881570 |
45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.42933927 |
46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.41529747 |
47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39268511 |
48 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.38486898 |
49 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.38340265 |
50 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.37497914 |
51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.34408986 |
52 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.34097751 |
53 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.33988325 |
54 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.33912317 |
55 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.33745650 |
56 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.31292300 |
57 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.30539854 |
58 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.29830559 |
59 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.29419369 |
60 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.27521050 |
61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27085477 |
62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26298113 |
63 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.25857546 |
64 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.25778760 |
65 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.25638789 |
66 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.25552529 |
67 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.25513576 |
68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25511614 |
69 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.25413313 |
70 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.25014041 |
71 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.24023626 |
72 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23782478 |
73 | MYB_26560356_Chip-Seq_TH2_Human | 1.21952477 |
74 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.21187982 |
75 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.20985115 |
76 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.19360786 |
77 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.18797259 |
78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18258948 |
79 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16812140 |
80 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.16333413 |
81 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.16087305 |
82 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.15855822 |
83 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.15144899 |
84 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15128952 |
85 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14921027 |
86 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.14569088 |
87 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.14171250 |
88 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.12572753 |
89 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.11597433 |
90 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.11574564 |
91 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.09914314 |
92 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.07010353 |
93 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.05280672 |
94 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02642370 |
95 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02026262 |
96 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.99004797 |
97 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98734049 |
98 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98431918 |
99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.98073395 |
100 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95922311 |
101 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93901047 |
102 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.93823283 |
103 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93734450 |
104 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.93594264 |
105 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92606596 |
106 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.92479300 |
107 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85874455 |
108 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.83966017 |
109 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.82841935 |
110 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.79928130 |
111 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.78496290 |
112 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77389319 |
113 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.77128701 |
114 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.75991954 |
115 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.75539615 |
116 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.75068937 |
117 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.74298776 |
118 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.73844420 |
119 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.72181901 |
120 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.70687191 |
121 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.70143573 |
122 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.67582611 |
123 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.66576045 |
124 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65446839 |
125 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.65354010 |
126 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.63217722 |
127 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.61962298 |
128 | P300_27268052_Chip-Seq_Bcells_Human | 0.61044017 |
129 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.59559977 |
130 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.59142166 |
131 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.58987769 |
132 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.58909987 |
133 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.58675583 |
134 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.58528662 |
135 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.58224691 |
136 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.57937478 |
137 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.57531335 |
138 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.57511277 |
139 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.56654136 |
140 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.56626658 |
141 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.55871290 |
142 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.55779444 |
143 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.55422619 |
144 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.55179309 |
145 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.55049546 |
146 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54981750 |
147 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.54672857 |
148 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.53412513 |
149 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.53332949 |
150 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.53206523 |
151 | P68_20966046_ChIP-Seq_HELA_Human | 0.52748361 |
152 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.52726415 |
153 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.52694562 |
154 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.52501710 |
155 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.52420823 |
156 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.51472550 |
157 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.51301297 |
158 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51296837 |
159 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.51166389 |
160 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.51105357 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.74321359 |
2 | MP0005360_urolithiasis | 6.75213305 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.82755141 |
4 | MP0005365_abnormal_bile_salt | 5.80495421 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.72960450 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.20806058 |
7 | MP0010329_abnormal_lipoprotein_level | 3.74417913 |
8 | MP0009840_abnormal_foam_cell | 3.68374813 |
9 | MP0003252_abnormal_bile_duct | 3.25553184 |
10 | MP0005671_abnormal_response_to | 3.16420551 |
11 | MP0001835_abnormal_antigen_presentation | 3.13867940 |
12 | MP0005332_abnormal_amino_acid | 2.83656451 |
13 | MP0005000_abnormal_immune_tolerance | 2.63104138 |
14 | MP0001666_abnormal_nutrient_absorption | 2.57934100 |
15 | MP0002148_abnormal_hypersensitivity_rea | 2.57223300 |
16 | MP0005083_abnormal_biliary_tract | 2.54110354 |
17 | MP0003195_calcinosis | 2.52643490 |
18 | MP0003191_abnormal_cellular_cholesterol | 2.52461898 |
19 | MP0001800_abnormal_humoral_immune | 2.48921159 |
20 | MP0009333_abnormal_splenocyte_physiolog | 2.48244071 |
21 | MP0003172_abnormal_lysosome_physiology | 2.46180109 |
22 | MP0002723_abnormal_immune_serum | 2.33503977 |
23 | MP0002419_abnormal_innate_immunity | 2.33214001 |
24 | MP0003763_abnormal_thymus_physiology | 2.27718056 |
25 | MP0000609_abnormal_liver_physiology | 2.25986689 |
26 | MP0002118_abnormal_lipid_homeostasis | 2.25403491 |
27 | MP0005387_immune_system_phenotype | 2.25279746 |
28 | MP0001790_abnormal_immune_system | 2.25279746 |
29 | MP0004019_abnormal_vitamin_homeostasis | 2.21661746 |
30 | MP0002452_abnormal_antigen_presenting | 2.20953707 |
31 | MP0002420_abnormal_adaptive_immunity | 2.20675729 |
32 | MP0001819_abnormal_immune_cell | 2.18203526 |
33 | MP0003303_peritoneal_inflammation | 2.18024280 |
34 | MP0000685_abnormal_immune_system | 2.11504873 |
35 | MP0002138_abnormal_hepatobiliary_system | 1.98123897 |
36 | MP0005319_abnormal_enzyme/_coenzyme | 1.93403232 |
37 | MP0001764_abnormal_homeostasis | 1.91151150 |
38 | MP0009278_abnormal_bone_marrow | 1.88628393 |
39 | MP0005670_abnormal_white_adipose | 1.87012987 |
40 | MP0005451_abnormal_body_composition | 1.85245121 |
41 | MP0003186_abnormal_redox_activity | 1.77944060 |
42 | MP0010155_abnormal_intestine_physiology | 1.69132845 |
43 | MP0000716_abnormal_immune_system | 1.69100620 |
44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.64385658 |
45 | MP0005075_abnormal_melanosome_morpholog | 1.64378219 |
46 | MP0002398_abnormal_bone_marrow | 1.59937163 |
47 | MP0001873_stomach_inflammation | 1.59406422 |
48 | MP0003011_delayed_dark_adaptation | 1.55466766 |
49 | MP0003868_abnormal_feces_composition | 1.53147309 |
50 | MP0001986_abnormal_taste_sensitivity | 1.49494935 |
51 | MP0003656_abnormal_erythrocyte_physiolo | 1.46629750 |
52 | MP0002876_abnormal_thyroid_physiology | 1.45622102 |
53 | MP0000689_abnormal_spleen_morphology | 1.45271626 |
54 | MP0009643_abnormal_urine_homeostasis | 1.44740355 |
55 | MP0002405_respiratory_system_inflammati | 1.43589409 |
56 | MP0001533_abnormal_skeleton_physiology | 1.40852068 |
57 | MP0002429_abnormal_blood_cell | 1.39830105 |
58 | MP0002722_abnormal_immune_system | 1.38790245 |
59 | MP0003866_abnormal_defecation | 1.36735196 |
60 | MP0006036_abnormal_mitochondrial_physio | 1.35454855 |
61 | MP0009697_abnormal_copulation | 1.32450825 |
62 | MP0003787_abnormal_imprinting | 1.21938772 |
63 | MP0000598_abnormal_liver_morphology | 1.20899272 |
64 | MP0001905_abnormal_dopamine_level | 1.19429136 |
65 | MP0002653_abnormal_ependyma_morphology | 1.17776494 |
66 | MP0005647_abnormal_sex_gland | 1.15836768 |
67 | MP0005310_abnormal_salivary_gland | 1.14890630 |
68 | MP0004130_abnormal_muscle_cell | 1.14262663 |
69 | MP0003123_paternal_imprinting | 1.11821618 |
70 | MP0000465_gastrointestinal_hemorrhage | 1.11274743 |
71 | MP0000703_abnormal_thymus_morphology | 1.06968963 |
72 | MP0005636_abnormal_mineral_homeostasis | 1.06141423 |
73 | MP0000604_amyloidosis | 1.06122745 |
74 | MP0001661_extended_life_span | 1.05333846 |
75 | MP0004510_myositis | 1.05224407 |
76 | MP0009763_increased_sensitivity_to | 1.04327909 |
77 | MP0002254_reproductive_system_inflammat | 1.04105204 |
78 | MP0001968_abnormal_touch/_nociception | 1.02971433 |
79 | MP0008469_abnormal_protein_level | 1.02967718 |
80 | MP0002163_abnormal_gland_morphology | 1.01833159 |
81 | MP0005666_abnormal_adipose_tissue | 1.01458243 |
82 | MP0009764_decreased_sensitivity_to | 1.00853476 |
83 | MP0000858_altered_metastatic_potential | 0.99620996 |
84 | MP0002971_abnormal_brown_adipose | 0.99413815 |
85 | MP0005397_hematopoietic_system_phenotyp | 0.99085212 |
86 | MP0001545_abnormal_hematopoietic_system | 0.99085212 |
87 | MP0003646_muscle_fatigue | 0.98249588 |
88 | MP0003718_maternal_effect | 0.97662857 |
89 | MP0003183_abnormal_peptide_metabolism | 0.94443586 |
90 | MP0005334_abnormal_fat_pad | 0.93380653 |
91 | MP0000343_altered_response_to | 0.91885976 |
92 | MP0009642_abnormal_blood_homeostasis | 0.91664454 |
93 | MP0005166_decreased_susceptibility_to | 0.91526262 |
94 | MP0001756_abnormal_urination | 0.91048050 |
95 | MP0000015_abnormal_ear_pigmentation | 0.90646780 |
96 | MP0002078_abnormal_glucose_homeostasis | 0.88884515 |
97 | MP0005535_abnormal_body_temperature | 0.88715183 |
98 | MP0003724_increased_susceptibility_to | 0.88591994 |
99 | MP0005376_homeostasis/metabolism_phenot | 0.87636180 |
100 | MP0001663_abnormal_digestive_system | 0.82649163 |
101 | MP0009765_abnormal_xenobiotic_induced | 0.80820762 |
102 | MP0005266_abnormal_metabolism | 0.80290493 |
103 | MP0002693_abnormal_pancreas_physiology | 0.79749915 |
104 | MP0005084_abnormal_gallbladder_morpholo | 0.78672542 |
105 | MP0002837_dystrophic_cardiac_calcinosis | 0.78309284 |
106 | MP0003705_abnormal_hypodermis_morpholog | 0.77441672 |
107 | MP0006035_abnormal_mitochondrial_morpho | 0.77224667 |
108 | MP0002933_joint_inflammation | 0.75655539 |
109 | MP0000490_abnormal_crypts_of | 0.74911188 |
110 | MP0003329_amyloid_beta_deposits | 0.70716813 |
111 | MP0005408_hypopigmentation | 0.70042151 |
112 | MP0005448_abnormal_energy_balance | 0.68841618 |
113 | MP0001853_heart_inflammation | 0.66281854 |
114 | MP0000681_abnormal_thyroid_gland | 0.65955244 |
115 | MP0002019_abnormal_tumor_incidence | 0.65788045 |
116 | MP0003690_abnormal_glial_cell | 0.65604504 |
117 | MP0005379_endocrine/exocrine_gland_phen | 0.65034714 |
118 | MP0004185_abnormal_adipocyte_glucose | 0.61431308 |
119 | MP0002970_abnormal_white_adipose | 0.60361644 |
120 | MP0009115_abnormal_fat_cell | 0.60272261 |
121 | MP0002822_catalepsy | 0.59922400 |
122 | MP0002796_impaired_skin_barrier | 0.59519695 |
123 | MP0005395_other_phenotype | 0.58428475 |
124 | MP0003436_decreased_susceptibility_to | 0.58407529 |
125 | MP0005220_abnormal_exocrine_pancreas | 0.56492660 |
126 | MP0002136_abnormal_kidney_physiology | 0.55869056 |
127 | MP0004782_abnormal_surfactant_physiolog | 0.55296109 |
128 | MP0003638_abnormal_response/metabolism_ | 0.51455349 |
129 | MP0005058_abnormal_lysosome_morphology | 0.51404486 |
130 | MP0003953_abnormal_hormone_level | 0.51024871 |
131 | MP0008260_abnormal_autophagy | 0.50051952 |
132 | MP0008873_increased_physiological_sensi | 0.49843373 |
133 | MP0002132_abnormal_respiratory_system | 0.49130213 |
134 | MP0001881_abnormal_mammary_gland | 0.48903729 |
135 | MP0005464_abnormal_platelet_physiology | 0.48491409 |
136 | MP0009785_altered_susceptibility_to | 0.48211948 |
137 | MP0004147_increased_porphyrin_level | 0.48024744 |
138 | MP0000230_abnormal_systemic_arterial | 0.45765884 |
139 | MP0008872_abnormal_physiological_respon | 0.45214871 |
140 | MP0001845_abnormal_inflammatory_respons | 0.44912062 |
141 | MP0005375_adipose_tissue_phenotype | 0.44012127 |
142 | MP0000639_abnormal_adrenal_gland | 0.43230492 |
143 | MP0004381_abnormal_hair_follicle | 0.42063094 |
144 | MP0009672_abnormal_birth_weight | 0.40412560 |
145 | MP0001243_abnormal_dermal_layer | 0.39396579 |
146 | MP0010368_abnormal_lymphatic_system | 0.39363023 |
147 | MP0008874_decreased_physiological_sensi | 0.38380522 |
148 | MP0006082_CNS_inflammation | 0.36112643 |
149 | MP0003075_altered_response_to | 0.33416116 |
150 | MP0005452_abnormal_adipose_tissue | 0.32970951 |
151 | MP0000249_abnormal_blood_vessel | 0.32111133 |
152 | MP0005025_abnormal_response_to | 0.31248361 |
153 | MP0004947_skin_inflammation | 0.29629227 |
154 | MP0009053_abnormal_anal_canal | 0.28614445 |
155 | MP0002269_muscular_atrophy | 0.28143313 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.72283935 |
2 | Intrahepatic cholestasis (HP:0001406) | 5.93565836 |
3 | Deep venous thrombosis (HP:0002625) | 5.89125401 |
4 | Xanthomatosis (HP:0000991) | 5.87603969 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.65903216 |
6 | Hypobetalipoproteinemia (HP:0003563) | 5.61857134 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 5.46174806 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.43138700 |
9 | Hyperglycinuria (HP:0003108) | 4.99279259 |
10 | Hyperglycinemia (HP:0002154) | 4.96269324 |
11 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.63395158 |
12 | Abnormality of glycine metabolism (HP:0010895) | 4.63395158 |
13 | Hyperammonemia (HP:0001987) | 4.60325770 |
14 | Hypolipoproteinemia (HP:0010981) | 4.43765078 |
15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.32857694 |
16 | Complement deficiency (HP:0004431) | 4.28898334 |
17 | Ketosis (HP:0001946) | 4.27016929 |
18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.11246885 |
19 | Hypoalphalipoproteinemia (HP:0003233) | 4.06120932 |
20 | Hypoglycemic coma (HP:0001325) | 3.92672789 |
21 | Epidermoid cyst (HP:0200040) | 3.85087202 |
22 | Joint hemorrhage (HP:0005261) | 3.84999711 |
23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.81877515 |
24 | * Abnormality of fatty-acid metabolism (HP:0004359) | 3.80971469 |
25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.74936592 |
26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.74391965 |
27 | Abnormality of methionine metabolism (HP:0010901) | 3.60459833 |
28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.54134691 |
29 | Fat malabsorption (HP:0002630) | 3.52553647 |
30 | Stomatitis (HP:0010280) | 3.48454096 |
31 | Myositis (HP:0100614) | 3.46550089 |
32 | Abnormality of serum amino acid levels (HP:0003112) | 3.41125593 |
33 | * Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.39309918 |
34 | Hypercholesterolemia (HP:0003124) | 3.37287076 |
35 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.34338607 |
36 | Dicarboxylic aciduria (HP:0003215) | 3.34338607 |
37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.33600291 |
38 | Recurrent abscess formation (HP:0002722) | 3.32927715 |
39 | Abnormality of macrophages (HP:0004311) | 3.22099150 |
40 | Ketoacidosis (HP:0001993) | 3.17464705 |
41 | Conjugated hyperbilirubinemia (HP:0002908) | 3.13563757 |
42 | Lethargy (HP:0001254) | 3.12515438 |
43 | Abnormality of the intrinsic pathway (HP:0010989) | 3.11352598 |
44 | Abnormality of complement system (HP:0005339) | 3.09833490 |
45 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.07151543 |
46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.07151543 |
47 | Abnormality of glycolipid metabolism (HP:0010969) | 3.07151543 |
48 | Recurrent bacterial skin infections (HP:0005406) | 3.03721990 |
49 | Hyperbilirubinemia (HP:0002904) | 3.03109376 |
50 | Hepatocellular necrosis (HP:0001404) | 2.99793898 |
51 | Abnormality of nucleobase metabolism (HP:0010932) | 2.97449299 |
52 | Gout (HP:0001997) | 2.92473248 |
53 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.91687906 |
54 | Increased cerebral lipofuscin (HP:0011813) | 2.91664932 |
55 | Metabolic acidosis (HP:0001942) | 2.91470496 |
56 | Mediastinal lymphadenopathy (HP:0100721) | 2.91322301 |
57 | Cerebral edema (HP:0002181) | 2.86839552 |
58 | Obstructive lung disease (HP:0006536) | 2.86079979 |
59 | Chronic obstructive pulmonary disease (HP:0006510) | 2.86079979 |
60 | Abnormality of purine metabolism (HP:0004352) | 2.79373803 |
61 | Eczematoid dermatitis (HP:0000976) | 2.79291301 |
62 | Dysostosis multiplex (HP:0000943) | 2.79229941 |
63 | Delayed CNS myelination (HP:0002188) | 2.75352876 |
64 | Orchitis (HP:0100796) | 2.73685793 |
65 | Skin nodule (HP:0200036) | 2.72165010 |
66 | Steatorrhea (HP:0002570) | 2.69094653 |
67 | Mitochondrial inheritance (HP:0001427) | 2.66940679 |
68 | Increased serum ferritin (HP:0003281) | 2.66587835 |
69 | Vacuolated lymphocytes (HP:0001922) | 2.64995118 |
70 | Petechiae (HP:0000967) | 2.62484964 |
71 | Increased intramyocellular lipid droplets (HP:0012240) | 2.62025191 |
72 | Myocardial infarction (HP:0001658) | 2.58909703 |
73 | Generalized aminoaciduria (HP:0002909) | 2.57974318 |
74 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.52675163 |
75 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.52675163 |
76 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.52675163 |
77 | Meningitis (HP:0001287) | 2.50748091 |
78 | Optic neuritis (HP:0100653) | 2.50680218 |
79 | Retrobulbar optic neuritis (HP:0100654) | 2.50680218 |
80 | Spontaneous abortion (HP:0005268) | 2.50647343 |
81 | Hepatocellular carcinoma (HP:0001402) | 2.44060659 |
82 | Irritability (HP:0000737) | 2.43627506 |
83 | Vomiting (HP:0002013) | 2.41509368 |
84 | Systemic lupus erythematosus (HP:0002725) | 2.41276369 |
85 | Increased IgM level (HP:0003496) | 2.39965980 |
86 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.39805825 |
87 | Hepatic necrosis (HP:0002605) | 2.38043620 |
88 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.35663082 |
89 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.34610983 |
90 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.33307334 |
91 | J-shaped sella turcica (HP:0002680) | 2.32100930 |
92 | Progressive microcephaly (HP:0000253) | 2.30721120 |
93 | Pustule (HP:0200039) | 2.30569442 |
94 | Prolonged neonatal jaundice (HP:0006579) | 2.30418786 |
95 | Pancreatitis (HP:0001733) | 2.29864194 |
96 | Encephalitis (HP:0002383) | 2.29204578 |
97 | Vasculitis (HP:0002633) | 2.29195242 |
98 | Hypertriglyceridemia (HP:0002155) | 2.29046920 |
99 | Recurrent fungal infections (HP:0002841) | 2.28235305 |
100 | Urticaria (HP:0001025) | 2.26614543 |
101 | Abnormal gallbladder morphology (HP:0012437) | 2.26375871 |
102 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.25879917 |
103 | Mucopolysacchariduria (HP:0008155) | 2.25879917 |
104 | Acanthocytosis (HP:0001927) | 2.25856391 |
105 | Nausea (HP:0002018) | 2.25352707 |
106 | Malnutrition (HP:0004395) | 2.24249403 |
107 | Cholelithiasis (HP:0001081) | 2.23276864 |
108 | Increased CSF lactate (HP:0002490) | 2.23255553 |
109 | Type I transferrin isoform profile (HP:0003642) | 2.21475462 |
110 | Opisthotonus (HP:0002179) | 2.20313858 |
111 | Acute necrotizing encephalopathy (HP:0006965) | 2.20255722 |
112 | Hypoglycemic seizures (HP:0002173) | 2.18799259 |
113 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.17584897 |
114 | * Brushfield spots (HP:0001088) | 2.17403060 |
115 | Neonatal onset (HP:0003623) | 2.14912231 |
116 | Abnormal protein glycosylation (HP:0012346) | 2.14495740 |
117 | Abnormal glycosylation (HP:0012345) | 2.14495740 |
118 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.14495740 |
119 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.14495740 |
120 | Late onset (HP:0003584) | 2.14384125 |
121 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.13984224 |
122 | Abnormal cartilage morphology (HP:0002763) | 2.13843522 |
123 | Spastic diplegia (HP:0001264) | 2.12443812 |
124 | Proximal tubulopathy (HP:0000114) | 2.12423526 |
125 | Vascular calcification (HP:0004934) | 2.11854853 |
126 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.11766234 |
127 | Progressive neurologic deterioration (HP:0002344) | 2.11199463 |
128 | Hepatosplenomegaly (HP:0001433) | 2.10328786 |
129 | Sensorimotor neuropathy (HP:0007141) | 2.09962824 |
130 | Recurrent skin infections (HP:0001581) | 2.09030142 |
131 | Pulmonary infiltrates (HP:0002113) | 2.09022544 |
132 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.08963908 |
133 | Visual hallucinations (HP:0002367) | 2.08953067 |
134 | Glycosuria (HP:0003076) | 2.07927044 |
135 | Abnormality of urine glucose concentration (HP:0011016) | 2.07927044 |
136 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.07386753 |
137 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.07386753 |
138 | Lymphopenia (HP:0001888) | 2.07053739 |
139 | Abnormality of T cells (HP:0002843) | 2.06903544 |
140 | Cerebral palsy (HP:0100021) | 2.06668530 |
141 | Agammaglobulinemia (HP:0004432) | 2.05772420 |
142 | Loss of speech (HP:0002371) | 2.05016326 |
143 | Microretrognathia (HP:0000308) | 2.03730489 |
144 | Amyloidosis (HP:0011034) | 2.02933077 |
145 | Hyperuricemia (HP:0002149) | 2.02432020 |
146 | Increased purine levels (HP:0004368) | 2.02432020 |
147 | Lactic acidosis (HP:0003128) | 2.00852842 |
148 | Gastrointestinal inflammation (HP:0004386) | 2.00341029 |
149 | Inflammation of the large intestine (HP:0002037) | 1.97740948 |
150 | Recurrent viral infections (HP:0004429) | 1.96756963 |
151 | IgG deficiency (HP:0004315) | 1.96290690 |
152 | 3-Methylglutaconic aciduria (HP:0003535) | 1.95843599 |
153 | Panhypogammaglobulinemia (HP:0003139) | 1.93838138 |
154 | Cholecystitis (HP:0001082) | 1.92980430 |
155 | Abnormal gallbladder physiology (HP:0012438) | 1.92980430 |
156 | Lipid accumulation in hepatocytes (HP:0006561) | 1.92239735 |
157 | Spastic paraparesis (HP:0002313) | 1.92101837 |
158 | Increased serum lactate (HP:0002151) | 1.91802620 |
159 | Acute encephalopathy (HP:0006846) | 1.91526155 |
160 | Hydroxyprolinuria (HP:0003080) | 1.91373189 |
161 | Abnormality of proline metabolism (HP:0010907) | 1.91373189 |
162 | Hypochromic microcytic anemia (HP:0004840) | 1.90351501 |
163 | Elevated hepatic transaminases (HP:0002910) | 1.89212393 |
164 | Gastrointestinal infarctions (HP:0005244) | 1.89007860 |
165 | Increased muscle lipid content (HP:0009058) | 1.88728439 |
166 | Gastrointestinal stroma tumor (HP:0100723) | 1.88603655 |
167 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.88218747 |
168 | Menorrhagia (HP:0000132) | 1.87190770 |
169 | Anorexia (HP:0002039) | 1.87180875 |
170 | Purpura (HP:0000979) | 1.87132972 |
171 | Alkalosis (HP:0001948) | 1.85354615 |
172 | CNS demyelination (HP:0007305) | 1.85181350 |
173 | Leukocytosis (HP:0001974) | 1.85025213 |
174 | Hyperglycemia (HP:0003074) | 1.84801591 |
175 | Glomerulonephritis (HP:0000099) | 1.84174891 |
176 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84102400 |
177 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.83713208 |
178 | Cardiovascular calcification (HP:0011915) | 1.82510030 |
179 | Mitral stenosis (HP:0001718) | 1.82381255 |
180 | Gingival bleeding (HP:0000225) | 1.82345063 |
181 | Colitis (HP:0002583) | 1.81722435 |
182 | Abnormality of iron homeostasis (HP:0011031) | 1.81709635 |
183 | Recurrent cutaneous fungal infections (HP:0011370) | 1.81697720 |
184 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.81697720 |
185 | Abnormality of T cell physiology (HP:0011840) | 1.80679028 |
186 | Renal cortical cysts (HP:0000803) | 1.80576804 |
187 | Hemorrhage of the eye (HP:0011885) | 1.79151089 |
188 | Hypertensive crisis (HP:0100735) | 1.78781721 |
189 | Hypergammaglobulinemia (HP:0010702) | 1.78401756 |
190 | Hypochromic anemia (HP:0001931) | 1.77843705 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.47455307 |
2 | EIF2AK1 | 4.09831096 |
3 | ERN1 | 4.05242652 |
4 | SIK1 | 3.21821244 |
5 | FGFR4 | 3.01861299 |
6 | MAP3K11 | 2.75496917 |
7 | VRK2 | 2.69853443 |
8 | EIF2AK3 | 2.69718685 |
9 | ARAF | 2.40280005 |
10 | MST1R | 2.24629106 |
11 | RIPK4 | 2.17091781 |
12 | NME2 | 2.15233251 |
13 | TXK | 2.07729701 |
14 | ACVR1B | 1.94312135 |
15 | INSRR | 1.89375969 |
16 | TESK1 | 1.88539036 |
17 | IRAK3 | 1.84704303 |
18 | TNK2 | 1.83338168 |
19 | PDK4 | 1.81271367 |
20 | PDK3 | 1.81271367 |
21 | FLT3 | 1.81050001 |
22 | TLK1 | 1.79978706 |
23 | PBK | 1.79273358 |
24 | TRIB3 | 1.77934292 |
25 | FES | 1.76723397 |
26 | CDK19 | 1.76618443 |
27 | TYK2 | 1.75959658 |
28 | STK16 | 1.74956415 |
29 | SMG1 | 1.71261628 |
30 | TAOK3 | 1.62154401 |
31 | EPHB1 | 1.59512424 |
32 | ABL2 | 1.55823317 |
33 | MAPKAPK3 | 1.41377456 |
34 | PRPF4B | 1.41181604 |
35 | KDR | 1.39985482 |
36 | BRAF | 1.33842146 |
37 | MAPK11 | 1.31596542 |
38 | PIK3CG | 1.31404260 |
39 | PINK1 | 1.29270582 |
40 | ERBB4 | 1.24273650 |
41 | BUB1 | 1.22819794 |
42 | ZAK | 1.22601340 |
43 | BRSK1 | 1.19417406 |
44 | SYK | 1.17200662 |
45 | TBK1 | 1.16397567 |
46 | PKN2 | 1.12423040 |
47 | MAP2K3 | 1.12283786 |
48 | PDK2 | 1.10627686 |
49 | MAP3K3 | 1.07546697 |
50 | DAPK1 | 1.06063160 |
51 | TAOK1 | 0.97883255 |
52 | MAP2K4 | 0.97815438 |
53 | TESK2 | 0.97141153 |
54 | AKT3 | 0.97101147 |
55 | MAP2K6 | 0.94310699 |
56 | GRK6 | 0.93816480 |
57 | CAMK1D | 0.92706525 |
58 | JAK3 | 0.91865009 |
59 | NEK9 | 0.91331422 |
60 | ITK | 0.90176458 |
61 | GRK5 | 0.89003728 |
62 | HIPK2 | 0.87010279 |
63 | EIF2AK2 | 0.85902770 |
64 | MAPK4 | 0.85579044 |
65 | ERBB2 | 0.84539352 |
66 | JAK2 | 0.83634421 |
67 | PRKAA2 | 0.83446999 |
68 | CDK4 | 0.83017664 |
69 | ADRBK2 | 0.82105612 |
70 | LYN | 0.81287714 |
71 | PRKD2 | 0.80033450 |
72 | LCK | 0.79714429 |
73 | HCK | 0.79023226 |
74 | ZAP70 | 0.78371050 |
75 | ICK | 0.78112935 |
76 | MAP2K1 | 0.74660826 |
77 | PIM1 | 0.72696285 |
78 | WEE1 | 0.71756587 |
79 | STK38L | 0.71608389 |
80 | MAP2K2 | 0.71388800 |
81 | PRKCI | 0.70904321 |
82 | MAPK7 | 0.70792864 |
83 | CAMKK1 | 0.70623343 |
84 | RPS6KL1 | 0.67740455 |
85 | RPS6KA2 | 0.67415907 |
86 | PRKACG | 0.67384124 |
87 | EPHA2 | 0.67294879 |
88 | LIMK1 | 0.67167411 |
89 | JAK1 | 0.67152071 |
90 | LRRK2 | 0.65087337 |
91 | SIK3 | 0.64499016 |
92 | MAP4K1 | 0.64371783 |
93 | CSK | 0.62873964 |
94 | PRKCQ | 0.62431542 |
95 | RPS6KA4 | 0.62371906 |
96 | BLK | 0.61632363 |
97 | PDPK1 | 0.61424875 |
98 | PRKCZ | 0.61374349 |
99 | GRK7 | 0.61298098 |
100 | PTK6 | 0.60217514 |
101 | MAP3K7 | 0.59813771 |
102 | NEK1 | 0.58503790 |
103 | MATK | 0.58415439 |
104 | MAPK12 | 0.57901656 |
105 | IKBKE | 0.57332598 |
106 | CAMK2G | 0.57161010 |
107 | RPS6KA5 | 0.57156298 |
108 | SIK2 | 0.55864361 |
109 | MARK2 | 0.55749050 |
110 | PRKAA1 | 0.55479558 |
111 | VRK1 | 0.54867907 |
112 | MAP3K1 | 0.53566095 |
113 | DAPK3 | 0.53105814 |
114 | MUSK | 0.51441788 |
115 | CSNK1G3 | 0.48346675 |
116 | MAP2K7 | 0.47394621 |
117 | CDK6 | 0.47351872 |
118 | STK11 | 0.46689224 |
119 | KIT | 0.45935017 |
120 | MAP3K13 | 0.45299800 |
121 | MAP3K14 | 0.44582144 |
122 | PAK1 | 0.43688715 |
123 | GSK3A | 0.43474139 |
124 | TIE1 | 0.42694712 |
125 | DYRK2 | 0.41416819 |
126 | DAPK2 | 0.39206652 |
127 | DYRK3 | 0.37933383 |
128 | PRKCH | 0.37090599 |
129 | MYLK | 0.36529875 |
130 | MAPK15 | 0.35943893 |
131 | PDK1 | 0.35564840 |
132 | PRKCD | 0.34472116 |
133 | IRAK2 | 0.34416372 |
134 | PIM2 | 0.32949810 |
135 | CSF1R | 0.32258602 |
136 | RAF1 | 0.31999962 |
137 | SCYL2 | 0.31818467 |
138 | MAP4K2 | 0.31792321 |
139 | IKBKB | 0.31115875 |
140 | CSNK1G1 | 0.27065636 |
141 | CSNK2A1 | 0.26451732 |
142 | BTK | 0.26383275 |
143 | BMPR1B | 0.26025144 |
144 | MET | 0.25546857 |
145 | PRKCG | 0.25389080 |
146 | PRKCA | 0.20615263 |
147 | AURKA | 0.19231994 |
148 | RPS6KA6 | 0.19091838 |
149 | TGFBR1 | 0.18776417 |
150 | GRK1 | 0.18663064 |
151 | FRK | 0.18603583 |
152 | IRAK4 | 0.18454178 |
153 | IRAK1 | 0.18429511 |
154 | IGF1R | 0.18342481 |
155 | TAOK2 | 0.18257622 |
156 | RPS6KC1 | 0.18256850 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.97099754 |
2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.24304606 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.04152403 |
4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.82563032 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.77661785 |
6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.69087739 |
7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.66616571 |
8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.64849116 |
9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.63818891 |
10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.63224339 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.62635217 |
12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55420514 |
13 | Allograft rejection_Homo sapiens_hsa05330 | 2.52376835 |
14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.50616902 |
15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.43637534 |
16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.37429519 |
17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.36747554 |
18 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.27112701 |
19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.24377681 |
20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23596498 |
21 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.22946513 |
22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.17497340 |
23 | * Peroxisome_Homo sapiens_hsa04146 | 2.11916799 |
24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.09977637 |
25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.07765278 |
26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.05078400 |
27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00549539 |
28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.86884953 |
29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86772119 |
30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.85002265 |
31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.83623330 |
32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.83467683 |
33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.83260883 |
34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.79655677 |
35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.77352275 |
36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.75769438 |
37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.75292981 |
38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.75125148 |
39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.73730135 |
40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.72693430 |
41 | Leishmaniasis_Homo sapiens_hsa05140 | 1.72673754 |
42 | Asthma_Homo sapiens_hsa05310 | 1.70019595 |
43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.69416258 |
44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69296420 |
45 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.68788035 |
46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.65911539 |
47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.63076527 |
48 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62961275 |
49 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.60748122 |
50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.60475355 |
51 | Ribosome_Homo sapiens_hsa03010 | 1.59389392 |
52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.57490463 |
53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54305946 |
54 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.53926915 |
55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.48621833 |
56 | RNA polymerase_Homo sapiens_hsa03020 | 1.48437891 |
57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47196323 |
58 | Tuberculosis_Homo sapiens_hsa05152 | 1.44761694 |
59 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.43191923 |
60 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43000281 |
61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.42821147 |
62 | Carbon metabolism_Homo sapiens_hsa01200 | 1.41744141 |
63 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40288413 |
64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.40274807 |
65 | Sulfur relay system_Homo sapiens_hsa04122 | 1.38170423 |
66 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.35618289 |
67 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34177383 |
68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.30493077 |
69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30314944 |
70 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.26700207 |
71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.24719092 |
72 | Base excision repair_Homo sapiens_hsa03410 | 1.24537251 |
73 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.24331531 |
74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.22377433 |
75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.22309023 |
76 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19635296 |
77 | Bile secretion_Homo sapiens_hsa04976 | 1.18114590 |
78 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16759219 |
79 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15380960 |
80 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.15335149 |
81 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.10894022 |
82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.09006564 |
83 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.08906522 |
84 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.07020071 |
85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06659433 |
86 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.06383732 |
87 | Malaria_Homo sapiens_hsa05144 | 1.05691047 |
88 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04026269 |
89 | ABC transporters_Homo sapiens_hsa02010 | 1.02910366 |
90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02592490 |
91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.99619750 |
92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98137487 |
93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.97973703 |
94 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96967834 |
95 | Measles_Homo sapiens_hsa05162 | 0.95738291 |
96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93952892 |
97 | Influenza A_Homo sapiens_hsa05164 | 0.90147992 |
98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89729015 |
99 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.88217513 |
100 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.86859008 |
101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85090739 |
102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83260777 |
103 | Shigellosis_Homo sapiens_hsa05131 | 0.83161524 |
104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83060922 |
105 | Pertussis_Homo sapiens_hsa05133 | 0.81741607 |
106 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80369822 |
107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.80342110 |
108 | Legionellosis_Homo sapiens_hsa05134 | 0.80138277 |
109 | Phagosome_Homo sapiens_hsa04145 | 0.79166942 |
110 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76696168 |
111 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.75964553 |
112 | Apoptosis_Homo sapiens_hsa04210 | 0.74415582 |
113 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72783978 |
114 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66268007 |
115 | Metabolic pathways_Homo sapiens_hsa01100 | 0.63512815 |
116 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59940452 |
117 | Salmonella infection_Homo sapiens_hsa05132 | 0.58892812 |
118 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.58716316 |
119 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57908015 |
120 | Endocytosis_Homo sapiens_hsa04144 | 0.57678189 |
121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57571231 |
122 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57272490 |
123 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56759634 |
124 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55008491 |
125 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54740788 |
126 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53882270 |
127 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53401773 |
128 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.51515358 |
129 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.51304118 |
130 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50354291 |
131 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50132370 |
132 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49749020 |
133 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48193727 |
134 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47241090 |
135 | Lysine degradation_Homo sapiens_hsa00310 | 0.45102669 |
136 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43543001 |
137 | Hepatitis B_Homo sapiens_hsa05161 | 0.41140139 |
138 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.38977007 |
139 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38743420 |
140 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38729166 |
141 | Proteasome_Homo sapiens_hsa03050 | 0.37558302 |
142 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30092251 |
143 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25090957 |
144 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.22621125 |
145 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.17969019 |
146 | Insulin resistance_Homo sapiens_hsa04931 | 0.16471385 |
147 | Parkinsons disease_Homo sapiens_hsa05012 | 0.13154478 |
148 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.12137111 |
149 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.10759822 |
150 | Prion diseases_Homo sapiens_hsa05020 | 0.09533000 |
151 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.07113215 |
152 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.00271727 |
153 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1846478 |
154 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1836832 |
155 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1827940 |
156 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1818944 |
157 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1808731 |
158 | Hepatitis C_Homo sapiens_hsa05160 | -0.1733633 |
159 | Lysosome_Homo sapiens_hsa04142 | -0.1628080 |
160 | Purine metabolism_Homo sapiens_hsa00230 | -0.1426600 |
161 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1341559 |
162 | Huntingtons disease_Homo sapiens_hsa05016 | -0.1023895 |
163 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0682477 |
164 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0383659 |
165 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0141476 |